[HTML][HTML] Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders

RF Spaide, CMG Cheung, H Matsumoto, S Kishi… - Progress in retinal and …, 2022 - Elsevier
In central serous chorioretinopathy (CSC), the macula is detached because of fluid leakage
at the level of the retinal pigment epithelium. The fluid appears to originate from choroidal …

[HTML][HTML] Central serous chorioretinopathy: An evidence-based treatment guideline

HMA Feenstra, EHC Van Dijk, CMG Cheung… - Progress in Retinal and …, 2024 - Elsevier
Central serous chorioretinopathy (CSC) is a relatively common disease that causes vision
loss due to macular subretinal fluid leakage and it is often associated with reduced vision …

Towards a better understanding of non-exudative choroidal and macular neovascularization

R Sacconi, S Fragiotta, D Sarraf, SVR Sadda… - Progress in Retinal and …, 2023 - Elsevier
Non-exudative macular and choroidal neovascularization (MNV and CNV) usually refers to
the entity of treatment-naïve type 1 neovascularization in the absence of associated signs of …

Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities

R Kaye, S Chandra, J Sheth, CJF Boon… - Progress in Retinal and …, 2020 - Elsevier
Central serous chorioretinopathy (CSC) is a common form of vision loss, typically seen in
working-age men. The pathophysiology behind CSC still eludes us, however significant …

Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects

M Farrag, D Ait Eldjoudi… - Frontiers in …, 2023 - frontiersin.org
Adipose tissue malfunction leads to altered adipokine secretion which might consequently
contribute to an array of metabolic diseases spectrum including obesity, diabetes mellitus …

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double …

A Lotery, S Sivaprasad, A O'Connell, RA Harris… - The Lancet, 2020 - thelancet.com
Background In chronic central serous chorioretinopathy (CSCR), fluid accumulates in the
subretinal space. CSCR is a common visually disabling condition that develops in …

Central serous chorioretinopathy: a review

AT Fung, Y Yang, AW Kam - Clinical & experimental …, 2023 - Wiley Online Library
Central serous chorioretinopathy (CSC) is the fourth most common non‐surgical retinopathy
associated with fluid leakage. The pathogenesis is not yet completely understood, but …

Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care

MJ Sirks, EHC van Dijk, N Rosenberg… - Acta …, 2022 - Wiley Online Library
Abstract Introduction Since July 2021, a worldwide shortage of verteporfin (Visudyne®)
occurred: an essential medicine required for photodynamic therapy (PDT). PDT with …

Fundus autofluorescence imaging

S Schmitz-Valckenberg, M Pfau, M Fleckenstein… - Progress in retinal and …, 2021 - Elsevier
Fundus autofluorescence (FAF) imaging is an in vivo imaging method that allows for
topographic map** of naturally or pathologically occurring intrinsic fluorophores of the …

[HTML][HTML] Scleral thickness in central serous chorioretinopathy

N Imanaga, N Terao, S Nakamine, T Tamashiro… - Ophthalmology …, 2021 - Elsevier
Purpose To evaluate scleral thickness in central serous chorioretinopathy (CSC) using
anterior segment (AS) OCT. Design Retrospective, comparative study. Participants Forty …